We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Oral voclosporin: novel calcineurin inhibitor for treatment of noninfectious uveitis.
- Authors
Roesel, Martin; Tappeiner, Christoph; Heiligenhaus, Arnd; Heinz, Carsten
- Abstract
Voclosporin, a novel immunomodulatory drug inhibiting the calcineurin enzyme, was developed to prevent organ graft rejection and to treat autoimmune diseases. The chemical structure of voclosporin is similar to that of cyclosporine A, with a difference in one amino acid, leading to superior calcineurin inhibition and less variability in plasma concentration. Compared with placebo, voclosporin may significantly reduce inflammation and prevent recurrences of inflammation in patients with noninfectious uveitis. Future studies have to show if these advantages are accompanied by greater clinical efficacy and fewer side effects compared with the classic calcineurin inhibitors.
- Publication
Clinical Ophthalmology, 2011, Vol 5, p1309
- ISSN
1177-5467
- Publication type
Article
- DOI
10.2147/OPTH.S11125